See also this year's filing and all EDGAR filings for this company.
PDF Report 0001420720_2020_iBio_Inc.pdf
Logs
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 14, '00201 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss CALC2': 2}} |
Graph
Absolute values for 0001420720, iBio Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 4,808,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,374,000 |
| 2 | PropertyPlantAndEquipmentNet | 24,380,000 |
| 3 | remainder_Assets | 24,000 |
| 4 | LiabilitiesCurrent | 3,458,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 24,671,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,458,492 |
| 9 | ResearchAndDevelopmentExpense | 5,156,502 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 1,576,231 |
| 12 | remainder_NetIncome | -1,829,068 |
| 13 | remainder_ComprehensiveNetIncome | -294 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 30,586,000 |
| 1 | Liabilities | 28,129,000 |
| 2 | Expenses | 17,614,994 |
| 3 | Revenues | 1,576,231 |
| 4 | StockholdersEquity | 2,457,000 |
| 5 | NetIncome | -17,867,831 |
| 6 | ComprehensiveNetIncome | -17,867,978 |
| 7 | BaseVar | 39,867,794 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.426 |
| 9 | EconomicCapitalRatio | 1.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
